17/04/2022
Endoscopic Ultrasound or EUS
Generally indicated for:
A. Staging tumors of the GI tract, pancreas, bile ducts, and mediastinum, including lung cancer.
B. Evaluating abnormalities of the GI tract wall or adjacent structures.
C. Tissue sampling of lesions within, or adjacent to, the wall of the GI tract.
D. Evaluation of abnormalities of the pancreas, including masses, pseudocysts, cysts, and chronic pancreatitis.
E. Evaluation of abnormalities of the biliary tree.
F. Placement of fiducials into tumors within or adjacent to the wall of the GI tract.
G. Treatment of symptomatic pseudocysts by creating an enteral-cyst communication.
H. Drug delivery (eg, celiac plexus neurolysis). I. Providing access into the bile ducts or pancreatic duct, either independently or as an adjunct to ERCP.
J. Evaluation for chronic pancreatitis.
K. Evaluation of acute pancreatitis of unknown etiology.
L. Evaluation for peria**l and perirectal disorders (a**l sphincter injuries, fistulae, abscesses).
M. Evaluation of patients at increased risk of pancreatic cancer.
EUS is generally not indicated for:
A. Staging of tumors shown to be metastatic by other imaging methods (unless the results are the basis for therapeutic decisions).
